Chemists have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing. These multilayer capsules show three traits that have been difficult to achieve in a single entity. They have good imaging contrast that allows detection with low-power ultrasound, they can stably and efficiently encapsulate the cancer drug doxorubicin, and both a low- and higher-power dose of ultrasound can trigger the release of that cargo.
More détails